SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹60 Cr | ₹60 Cr | ₹3.61 Cr | ₹3.22 Cr | ₹6.22 Cr |
What is the latest Contingent Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹3.61 Cr |
| Mar2022 | ₹3.22 Cr |
| Mar2021 | ₹6.22 Cr |
How is Contingent Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹60 Cr | -0.30 | |
| Mar2024 | ₹60 Cr | 1,563.71 | |
| Mar2023 | ₹3.61 Cr | 12.11 | |
| Mar2022 | ₹3.22 Cr | -48.23 | |
| Mar2021 | ₹6.22 Cr | - | |
Compare Contingent Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹2,754.1 Cr | -2.5% | 4.5% | 7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -2.5% |
4.5% |
7.2% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses